News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
490,153 Results
Type
Article (48741)
Company Profile (99)
Press Release (441313)
Section
Business (148756)
Career Advice (1542)
Deals (23391)
Drug Delivery (40)
Drug Development (55662)
Employer Resources (101)
FDA (9338)
Job Trends (10427)
News (238291)
Policy (18389)
Tag
Academia (2626)
Africa (623)
Alliances (38215)
Alzheimer's disease (991)
Approvals (9329)
Arizona (85)
Artificial intelligence (54)
Asia (28251)
Australia (5220)
Bankruptcy (157)
Best Places to Work (7887)
Biotechnology (67)
C2C Services and Suppliers (45833)
California (1348)
Canada (726)
Cancer (399)
Career advice (1293)
Cell therapy (100)
China (106)
Clinical research (42417)
Collaboration (144)
Colorado (52)
Connecticut (60)
COVID-19 (1895)
Cystic fibrosis (55)
Data (326)
Diabetes (49)
Diagnostics (4270)
Earnings (56845)
Employer resources (90)
Europe (66467)
Events (68966)
Executive appointments (136)
FDA (9513)
Florida (208)
Funding (124)
Gene therapy (61)
Georgia (38)
GLP-1 (342)
Government (2332)
Healthcare (12895)
Hotbed/Location (321773)
Illinois (169)
Indiana (100)
Infectious disease (1913)
Inflammatory bowel disease (72)
Interviews (289)
IPO (11045)
Job creations (2671)
Job search strategy (1135)
Kansas (52)
Layoffs (247)
Legal (4078)
Lung cancer (79)
Maine (43)
Manufacturing (60)
Maryland (254)
Massachusetts (1039)
Medical device (7894)
Medtech (7896)
Mergers & acquisitions (12332)
Metabolic disorders (146)
Michigan (108)
Minnesota (131)
Neuroscience (1122)
New Jersey (487)
New York (477)
NextGen Class of 2024 (4231)
Non-profit (3784)
North Carolina (464)
Northern California (627)
Obesity (81)
Ohio (82)
Opinion (129)
Parkinson's disease (38)
Patents (38)
Pennsylvania (356)
People (43262)
Phase I (13171)
Phase II (18198)
Phase III (14318)
Pipeline (115)
Postmarket research (2038)
Preclinical (6906)
Press Release (71)
Radiopharmaceuticals (187)
Rare diseases (97)
Real estate (4488)
Recruiting (38)
Regulatory (12596)
Research institute (2500)
Resumes & cover letters (222)
South America (754)
Southern California (557)
Startups (2555)
Texas (171)
United States (6120)
Vaccines (341)
Washington State (196)
Weight loss (61)
Date
Today (94)
Last 7 days (411)
Last 30 days (1758)
Last 365 days (26359)
2024 (19112)
2023 (29140)
2022 (39320)
2021 (41996)
2020 (39232)
2019 (32343)
2018 (24381)
2017 (23373)
2016 (23182)
2015 (28288)
2014 (22101)
2013 (19179)
2012 (19436)
2011 (20400)
2010 (19379)
490,153 Results for "semiconductor research corporation src".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Bio NC
Semiconductor Research Corporation announces 2023 Call for Research, $16.5M in Funding Opportunities
Semiconductor Research Corporation, a premier research and workforce development consortium, is announcing the launch of solicitation season.
April 3, 2023
·
2 min read
Pharm Country
Aprea Therapeutics Announces that Safety Review Committee (SRC) Endorses Dosing of Patients with ATRN-119 at 800 mg Once Daily in Ongoing ABOYA-119 Clinical Trial
Aprea Therapeutics, Inc. today announced that the Safety Review Committee (SRC) overseeing the ongoing ABOYA-119 clinical trial has determined that dosing of patients with ATRN-119 at 800 mg once daily (Cohort 6) can commence and that Cohort 6 is open for enrollment.
May 28, 2024
·
7 min read
Biotech Beach
Semiconductor Research Corporation invites Cardea to be part of defining how to integrate biology with electronics
As part of the Semiconductor Research Corporation (SRC) being selected by NIST’s Advanced Manufacturing Office to define the future of Microelectronics and Advanced Packaging Technology (MAPT), Cardea Bio has been invited as a commercial semiconductor company to share their experience with integrating biology with electronics.
August 25, 2022
·
4 min read
Business
Todd Younkin Appointed President and CEO of Semiconductor Research Corporation (SRC)
Semiconductor Research Corporation (SRC), a leading global semiconductor research consortium, today announced the appointment of industry veteran Todd Younkin as President and Chief Executive Officer. Younkin’s appointment was made by SRC’s Board of Directors. Younkin will start transitioning to his new role on August 18, 2020.
August 7, 2020
·
4 min read
Biotech Bay
Twist Bioscience Announces Participation in SRC-SIA Webinar on the Decadal Plan for Semiconductors
Twist Bioscience Corporation today announced that Steffen Hellmold, senior vice president, business development, data storage, will participate in the virtual SRC-SIA Webinar on the Decadal Plan for Semiconductors held on December 9, 2021 from 12:30pm to 2:00pm (EST).
November 30, 2021
·
4 min read
Drug Development
Pasithea Therapeutics Announces Completion of Enrollment and Initial Dosing of Cohort 2 following Positive Safety Review Committee (SRC) Recommendation for PAS-004 in Ongoing Phase 1 Clinical Trial
Pasithea Therapeutics Corp. announced that an independent Safety Review Committee has completed its safety review of data from the first dose cohort treated in the ongoing Phase 1 clinical trial of PAS-004 in patients with MAPK pathway driven advanced solid tumors with a documented RAS, NF1 or RAF mutation or patients who have failed BRAF/MEK inhibition.
June 13, 2024
·
3 min read
Deals
Bruker Acquires Nanophoton Corporation, a Japanese Technology Leader in Research Raman Microscopy with 20 Years of Experience
Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Nanophoton Corporation, a pioneer focused on advanced research Raman microscopy systems.
February 7, 2024
·
4 min read
BioCapital
Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research Alternatives
Charles River Laboratories International, Inc. announced a multidisciplinary program, funded through a $1.3 million grant from the Foundation for Chemistry Research & Initiatives, in coordination with the American Chemistry Council’s Long-Range Research Initiative, to develop a New Approach Methodology inhalation toxicology test to reduce reliance on traditional animal research methods.
June 11, 2024
·
4 min read
BioMidwest
C2N Diagnostics Expands Into Japan Through Mediford Corporation Partnership With Precivity™ Blood Testing for Alzheimer’s Disease and Brain Research Market
C₂N Diagnostics, LLC announced a partnership agreement with Mediford Corporation, a PHC Holdings Corporation Group Company and premier provider of clinical research to the biopharma industry throughout Japan.
April 26, 2024
·
6 min read
Press Releases
Therma Bright Investment Portfolio Company InStatin Secures Mountain West Research Discovery Study Agreement
Clinical research will offer insight for specific targeting of active pharmaceutical ingredients (API) that will further support Phase 1 Human Trials
September 23, 2024
·
3 min read
1 of 49,016
Next